Esophageal squamous-cell carcinoma remains the predominant esophageal cancer in Asia, Africa, and South America and among African Americans in North America.

Drs Samuel Klempner and Geoffrey Ku deep dive into all things esophageal squamous cell cancer, including detection, staging, and treatment.

Abstract e16045 Background: Currently, the real-world evidence is not available to support the practice of induction immunochemotherapy (iIC) plus conversion surgery for initially-unresectable ...

Conversion surgery for tislelizumab combined chemotherapy for T4a/N3 esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II study.

Barrett’s Esophagus is a condition that rarely requires surgery, but when it progresses to high-grade dysplasia or esophageal cancer, surgical intervention becomes necessary. Esophageal surgery ...

Esophageal cancer is a malignant disease with high incidence and mortality, where esophageal squamous cell carcinoma (ESCC) is the most common histological subtype. To improve therapeutic approaches ...

Esophageal cancer is staged from 0 to 4. Lower stages indicate small, localized cancer. Higher stages indicate cancer has spread and may be harder to treat.

Squamous cell carcinoma: This arises from the cells lining the upper part of the esophagus. Adenocarcinoma of the esophagus: This occurs due to changes in the glandular cells that exist at the ...

Stage 4 esophageal cancer is an advanced for of cancer. Learn about symptom, treatments, diagnosis, survival rates, and more.

Key Takeaway Esophagectomy for esophageal squamous cell carcinoma (ESCC) should be performed 6–8 weeks after the end of neoadjuvant chemotherapy.